Treatment outcomes and costs of a simplified antiretroviral treatment strategy for hepatitis C among Hepatitis C Virus and Human Immuno deficiency Virus co‐infected patients in Ukraine

BACKGROUND AND AIM: To demonstrate the use of a standard dose of ledipasvir (LDV) and sofosbuvir (SOF), with or without ribavirin, to treat hepatitis C and hepatitis C/HIV co‐infection in Ukraine. METHODS: Eligible HCV viraemic adults from two clinics in Kyiv were treated with LDV/SOF with or withou...

Descripción completa

Detalles Bibliográficos
Autores principales: Antoniak, Sergie, Chasela, Charles S, Freiman, Morgan Julie, Stopolianska, Yulia, Barnard, Tetiana, Gandhi, Malini M, Liulchuk, Maria, Tsenilova, Zhanna, Viktor, Tretiakov, Dible, Jeri, Wose Kinge, Constance, Akpan, Francis, Minior, Thomas, Sigwebela, Ntombi, Mohamed, Sofiane, Barralon, Matthiue, Marange, Fadzai, Cavenaugh, Clint, Horst, Charles Vander, Antonyak, Svitlana, Xulu, Thembisile, Chew, Kara W, Sanne, Ian, Rosen, Sydney
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730727/
https://www.ncbi.nlm.nih.gov/pubmed/36514496
http://dx.doi.org/10.1002/jgh3.12839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730727/
https://www.ncbi.nlm.nih.gov/pubmed/36514496
http://dx.doi.org/10.1002/jgh3.12839

Ejemplares similares